Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.
about
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future ApplicationsHuman Stem Cell-Derived Endothelial-Hepatic Platform for Efficacy Testing of Vascular-Protective Metabolites from Nutraceuticals.Impact of fluidic agitation on human pluripotent stem cells in stirred suspension culture.Current state and perspectives in modeling and control of human pluripotent stem cell expansion processes in stirred-tank bioreactors.Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up.Characterization of companion animal pluripotent stem cells.Transfection in perfused microfluidic cell culture devices: A case study.Climbing the mountain: experimental design for the efficient optimization of stem cell bioprocessing.A simple and scalable hydrogel-based system for culturing protein-producing cells.An integrated experimental and economic evaluation of cell therapy affinity purification technologies.A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension.Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors.Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System.Effect of strontium citrate on bone consolidation during mandibular distraction osteogenesis.Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells.A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells
P2860
Q26772309-D32FF353-3289-4375-B51A-506E4DAB958CQ33722328-A021D7C2-E89F-40D8-859E-21F37EE6CCA3Q38686685-39B0EA24-F7DE-4B64-910C-B2DD4CA3FEF5Q39055581-8125EE8F-D7A9-4DD4-82A2-60660CE732CCQ39177046-D2D81CFF-73C8-422A-92D1-6B9CDE38EB2DQ39415327-C53657A1-2355-4FE0-A034-8C097DBDB5CEQ42141492-6E74A838-C753-4C26-BFB8-9C01EB18AFA4Q47134857-34E6F619-9AD3-4112-BD43-96653B286185Q47205410-233D3F9F-1BA8-46B0-856D-4D2BB536A542Q48012990-52B679A0-D146-46C1-A6DA-5747672B2521Q48109644-0562D91A-2DD8-4C4B-B97F-875BAEE00D26Q48313751-F98C73E1-45E4-445C-B8DA-A99EDBBF565EQ50334475-01913385-3C8C-4614-89A1-69FBE90C72A8Q53304831-C7108CFC-7312-4089-B4CF-98ACD03C91FEQ54985454-3A9D0B8B-E917-45F4-BB4F-AA85AA35271FQ58803059-60102589-6B05-4D6D-9D29-3C8C2F6ECF66
P2860
Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Human pluripotent stem cell-de ...... tive manufacturing strategies.
@ast
Human pluripotent stem cell-de ...... tive manufacturing strategies.
@en
type
label
Human pluripotent stem cell-de ...... tive manufacturing strategies.
@ast
Human pluripotent stem cell-de ...... tive manufacturing strategies.
@en
prefLabel
Human pluripotent stem cell-de ...... tive manufacturing strategies.
@ast
Human pluripotent stem cell-de ...... tive manufacturing strategies.
@en
P2860
P356
P1476
Human pluripotent stem cell-de ...... ctive manufacturing strategies
@en
P2093
Michael J Jenkins
P2860
P356
10.1002/BIOT.201400348
P577
2014-11-19T00:00:00Z